SecBot SecBot
Institutional Cluster

EBS

Emergent BioSolutions Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed2d 2h ago
Institutional cluster: 3 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

The cluster is small relative to EBS's $364M market cap and dominated by one fund's position. Monitor next 13F for whether Truist maintained or exited its stake, and watch for any insider buying to confirm conviction.

DirectionNeutral
Confidencemedium
Horizonweeks

Executive Summary

Three asset managers increased their EBS positions in Q3 2026, led by Truist Financial more than quadrupling its stake to $1.5M, while one advisor trimmed. The cluster is small in absolute dollar terms ($1.2M net buying) and lacks insider corroboration, suggesting limited conviction.

Key Financial Metrics

Direction
accumulating
Buy Value
$1.5M
Sell Value
$198.0K
Net Flow
$1.1M

Institutional Positions

Net institutional flow: $1.1M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Truist FinancialDOUBLED+426.9%$1.5M$1.2M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Wealth Enhancement Advisory ServicesTRIM-38.6%$198.0K-$95.0K

Key Facts

  • 3 institutional buyers added $1.2M in net new holdings in Q3 2026
  • Truist Financial doubled its position (+426.9% shares) to $1.5M
  • 1 seller reduced holdings by $95K
  • No open-market insider buying; insider-institutional confluence score is 3/100 (divergent)
  • Total net institutional inflow was approximately $1.1M

Financial Impact

Net institutional buying of ~$1.1M (3 buyers added $1.2M, 1 seller reduced by $95K); Truist Financial alone accounted for $1.2M of the increase

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • Cluster size is very small ($1.2M net) relative to market cap and normal daily move of 7.4%
  • No insider buying to corroborate the institutional signal
  • Only one fund (Truist) drove the bulk of the buying; the other two additions were negligible

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-EBS-2026-Q3
18 reports for EBS
Performance horizon
75% Hit rate @ T+5 3 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +14.89%Apr 29, 2026
Filters
Rows
Reports for EBS, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 2/10
$6.80awaiting T+5awaiting T+5No price
Oct 16, 2026
16d ago
8-K
NEUTRAL ★ 3/10
$6.38 $6.23▼ −2.35%▼ −2.44%No price
Oct 7, 2026
25d ago
144
NEUTRAL ★ 2/10
$6.81 $7.18▲ +5.43%▲ +5.71%No price
Jun 29, 2026
17w ago
8-K
BULLISH ★ 5/10
$8.46 $8.18▼ −3.31%▼ −4.70%No price
Jun 4, 2026
21w ago
Press Release
NEUTRAL ★ 2/10
$8.44 $8.39▼ −0.59%▲ +1.96%No price
Apr 30, 2026
26w ago
Press Release
MIXED ★ 6/10
$8.47 $9.13▲ +7.79%▲ +5.45%No price
Apr 30, 2026
26w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.23 $9.10▲ +10.57%▲ +8.84%No price
Apr 29, 2026
26w ago
Press Release
BULLISH ★ 4/10
$7.99 $9.10▲ +13.89%▲ +10.78%No price
Apr 29, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$7.99 $9.10▲ +13.89%▲ +10.78%No price
Apr 28, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $8.54▲ +3.77%▲ +2.07%No price
Showing 10 of 18

US Market Status

Market Closed · Opens Mon (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026